JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.17% |
| 2 | Healthcare | 10.79% |
| 3 | Financials | 9.36% |
| 4 | Consumer Discretionary | 8.67% |
| 5 | Industrials | 7.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5026
PUT
Delta Air Lines
DAL
$58.8B
| $140K | ﹤0.01% |
4,000
| – | – |
|
5027
Veritone
VERI
$116M
| $140K | ﹤0.01% |
23,963
+6,257
| +35% | +$43.1K |
|
5028
Willdan Group
WLDN
$1.32B
| $140K | ﹤0.01% |
8,936
-6,822
| -43% | -$122K |
|
5029
InflaRx
IFRX
$301M
| $139K | ﹤0.01% |
71,723
+61,963
| +635% | +$134K |
|
|
NNDM
5030
Nano Dimension
NNDM
$344M
| $139K | ﹤0.01% |
47,728
-27,387
| -36% | -$73.6K |
|
5031
CALL
Novavax
NVAX
$1.33B
| $139K | ﹤0.01% |
20,000
-976,900
| -98% | -$8.99M |
|
5032
Innovator US Equity Power Buffer ETF November
PNOV
$899M
| $139K | ﹤0.01% |
4,356
+1,340
| +44% | +$41.8K |
|
|
EOS
5033
Eaton Vance Enhance Equity Income Fund II
EOS
$1.18B
| $138K | ﹤0.01% |
8,420
+2,140
| +34% | +$35.5K |
|
5034
CALL
iShares Gold Trust
IAU
$64.9B
| $138K | ﹤0.01% |
+3,700
| New | +$133K |
|
5035
RGC Resources
RGCO
$224M
| $138K | ﹤0.01% |
+5,955
| New | +$141K |
|
|
FFAI
5036
Faraday Future Intelligent Electric
FFAI
$10M
| – | – |
0
| – | – |
|
5037
CALL
Peabody Energy
BTU
$3.11B
| $136K | ﹤0.01% |
5,300
+2,600
| +96% | +$69.1K |
|
5038
CALL
Fluence Energy
FLNC
$2.43B
| $136K | ﹤0.01% |
+6,700
| New | +$133K |
|
5039
CALL
Perrigo
PRGO
$1.81B
| $136K | ﹤0.01% |
+3,800
| New | +$137K |
|
|
YALA
5040
Yalla Group
YALA
$832M
| $136K | ﹤0.01% |
34,534
-3,033
| -8% | -$13.2K |
|
|
JAQC
5041
DELISTED
Jupiter Acquisition Corporation Common stock
JAQC
| $136K | ﹤0.01% |
13,400
-19,950
| -60% | -$200K |
|
5042
ProShares Ultra NASDAQ Biotechnology
BIB
$86.6M
| $135K | ﹤0.01% |
2,495
+504
| +25% | +$28.4K |
|
5043
Baytex Energy
BTE
$3.06B
| $135K | ﹤0.01% |
+36,162
| New | +$134K |
|
5044
Cohen & Steers Tax-Advantaged Preferred Securities & Income Fund
PTA
$1.05B
| $135K | ﹤0.01% |
+7,559
| New | +$143K |
|
5045
Tilly's
TLYS
$122M
| $135K | ﹤0.01% |
17,492
+4,522
| +35% | +$37.8K |
|
5046
Kayne Anderson Energy Infrastructure Fund
KYN
$2.51B
| $135K | ﹤0.01% |
15,551
+14,551
| +1,455% | +$128K |
|
5047
Adicet Bio
ACET
$78.4M
| $134K | ﹤0.01% |
1,458
+345
| +31% | +$43.3K |
|
|
KG
5048
Kestrel Group
KG
$61.7M
| $134K | ﹤0.01% |
3,205
+2,985
| +1,357% | +$138K |
|
5049
Outdoor Holding Co
POWW
$260M
| $134K | ﹤0.01% |
67,770
+17,845
| +36% | +$36.9K |
|
5050
Weyco Group
WEYS
$432M
| $134K | ﹤0.01% |
5,300
+567
| +12% | +$14.3K |
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 752 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 752 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.